JDD in the Media

Are Dermatologists Prepared for Natural and Manmade Disasters?

By January 31, 2020February 14th, 2020No Comments

Natural and manmade disasters cause a range of dermatologic manifestations, including secondary infections after a flood, irritation from blistering agents used in chemical warfare, or acute and chronic effects of cutaneous radiation syndrome.

In a study, “A Survey of Dermatologists’ Preparedness for Natural and Man-made Disasters,” (January 2020 Journal of Drugs in Dermatology), Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences, finds that dermatologists are under prepared for biological disasters, and would benefit from comprehensive preparedness training.
“Recognizing and diagnosing the conditions that can arise following a disaster requires diagnostic acumen, knowledge on reporting, and short- and long-term management strategies,” Dr. Friedman said.

The study cites a 2003 survey  in which that 88% of dermatologists felt unprepared to respond to a biological attack.

“Encouragingly, though, 75% reported that disaster preparedness should be part of dermatology training, thus a formal training program is sorely needed to meet this demand,” the study notes.

Read Article Now

You May Also Like

Featured ArticlesJDD HighlightsJDD in the MediaThe Latest
July 31, 2023

WATCH VIDEO ABSTRACT: Assessing Implicit Bias in Dermatology

Click Here to Watch Video Abstract   Background: Patients with skin of color (SOC), defined as Fitzpatrick skin types IV to VI, and of varying ethnicities are under-represented in dermatology. This…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaSkin of ColorThe Latest
July 27, 2023

Dermatology Roundup: Racial Differences in Melanoma Survival Rates, ASA Announces Research Scholar Award Recipients

By Allison Sit A study published in the Journal of the American Academy of Dermatology found men with melanoma – and particularly men with skin of color – are more…
Featured ArticlesJDD HighlightsJDD in the MediaThe Latest
July 20, 2023

JDD in the News: Increased Dose of Adalimumab in Overweight, Obese Patients; Topical for Infantile Hemangiomas

Healio covered a JDD study on the impact of an increased dose of adalimumab in hidradenitis suppurativa patients who are overweight or obese. Researchers from the University of California San…

Leave a Reply